JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259216

Human TWF1 (Twinfilin-1) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TWF1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and 2 bp deletion in exon3 and 61 bp insertion in exon3.

View Alternative Names

A6, A6 protein tyrosine kinase, MGC105817, MGC23788, MGC41876, PTK9, PTK9 protein tyrosine kinase 9, Protein A6, Protein tyrosine kinase 9, TWF1_HUMAN, Twinfilin, Twinfilin actin binding protein, homolog 1, Twinfilin, Drosophila, homolog of, 1, Twinfilin, actin-binding protein, homolog 1 (Drosophila), Twinfilin-1

3 Images
Sanger Sequencing - Human TWF1 (Twinfilin-1) knockout HeLa cell lysate (AB259216)
  • Sanger seq

Unknown

Sanger Sequencing - Human TWF1 (Twinfilin-1) knockout HeLa cell lysate (AB259216)

Allele-2 : 61 bp insertion in exon3

Sanger Sequencing - Human TWF1 (Twinfilin-1) knockout HeLa cell lysate (AB259216)
  • Sanger seq

Unknown

Sanger Sequencing - Human TWF1 (Twinfilin-1) knockout HeLa cell lysate (AB259216)

Allele-3 : 2 bp deletion in exon3

Sanger Sequencing - Human TWF1 (Twinfilin-1) knockout HeLa cell lysate (AB259216)
  • Sanger seq

Unknown

Sanger Sequencing - Human TWF1 (Twinfilin-1) knockout HeLa cell lysate (AB259216)

Allele-1 : 1 bp insertion in exon3

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and 2 bp deletion in exon3 and 61 bp insertion in exon3.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259216-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TWF1 knockout HeLa cell lysate", "number":"AB259216-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB259216-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
TWF1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TWF1 also known as Twinfilin-1 or A6-related protein is an actin-binding protein with a molecular mass of about 38 kDa. This protein is expressed in various tissues including skeletal muscle heart and brain. TWF1 playing a role in actin dynamics binds to actin monomers and may affect actin filament turnover. It acts by promoting actin depolymerization and inhibiting actin nucleation contributing to the dynamic remodeling of the actin cytoskeleton.
Biological function summary

TWF1 is important in regulating cell motility morphology and division by influencing actin filament dynamics. TWF1 does not necessarily exist as part of a complex but its activity interacts with components of the cytoskeleton. By modulating actin dynamics TWF1 influences processes such as endocytosis cellular movement and response to external stimuli.

Pathways

Actin dynamics mediated by TWF1 is integral to the cytoskeleton organization pathway and the endocytic pathway. Within these pathways it interacts indirectly with proteins like cofilin and profilin which also regulate actin cytoskeleton. Its activity helps cells to adapt their shape and movement facilitating diverse cellular functions and signaling processes.

TWF1 has relevance to cancer progression and conditions affecting cell mobility. Abnormal regulation of actin dynamics due to altered TWF1 activity might lead to enhanced cancer cell invasion and metastasis. Additionally TWF1 connects with proteins like ADF/Cofilin regarding cancer-related pathways influencing actin structure remodeling and cell movement in malignant cells.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com